초록

Graft materials and devices for surgical breast procedures, as well as methods of making graft devices are described.

대표청구항 ▼

1. A medical implant for surgical breast procedures, comprising: a sheet-like sample of biocompatible material;wherein the sample of biocompatible material includes a first edge and a second edge;wherein, when the sample of biocompatible material is in a planar configuration, the first edge includes

1. A medical implant for surgical breast procedures, comprising: a sheet-like sample of biocompatible material;wherein the sample of biocompatible material includes a first edge and a second edge;wherein, when the sample of biocompatible material is in a planar configuration, the first edge includes a convex portion that curves away from the second edge and the second edge includes a convex portion that curves away from the first edge;wherein the convex portion of the first edge includes a first vertex and the convex portion of the second edge includes a second vertex;wherein the sample of biocompatible material includes a longitudinal axis coincident with the sample of biocompatible material and a vertical axis coincident with the sample of biocompatible material, the vertical axis passing through the first and second vertices, and a distance along the longitudinal axis of the sample of biocompatible material being longer than a distance along the vertical axis of the sample of biocompatible material;wherein the vertical axis and the longitudinal axis are orthogonal to each other;wherein the convex portion of the first edge has a first radius of curvature and the convex portion of the second edge has a second radius of curvature, the first radius of curvature being different from the second radius of curvature;wherein the sample of biocompatible material is symmetrical about the vertical axis;wherein the sample of biocompatible material comprises an acellular tissue matrix;wherein the sample of biocompatible material has a set of perforations, the set of perforations including elongate slits arranged across at least a portion of the sample of biocompatible material, wherein ends of longitudinally-neighboring elongate slits are arranged adjacent to each other; andwherein the set of perforations forms an arcuate pattern extending along the longitudinal axis when the sheet-like sample of biocompatible material is in the planar configuration. 2. The medical implant of claim 1, wherein the sample of biocompatible material is biconvex in shape. 3. The medical implant of claim 1, wherein the first edge is substantially parabolicly curved. 4. The medical implant of claim 1, wherein the second edge is substantially parabolicly curved. 5. The medical implant of claim 1, wherein the first edge further includes a nonconvex portion. 6. The medical implant of claim 1, wherein the second edge further includes a nonconvex portion. 7. The medical implant of claim 1, wherein the second edge further includes a straight portion. 8. The medical implant of claim 1, wherein the first edge and the second edge are joined at apexes, and wherein at least one of the apexes is rounded. 9. The medical implant of claim 1, wherein the first edge and the second edge are joined at apexes, and wherein at least one of the apexes is squared. 10. The medical implant of claim 1, wherein the sample of biocompatible material is symmetrical about at least one axis. 11. The medical implant of claim 1, wherein the sample of biocompatible material is asymmetrical about the longitudinal axis. 12. The medical implant of claim 1, wherein the first vertex of the first edge is separated from a first focus of the first edge by a first length and the second vertex of the second edge is separated from a second focus of the second edge by a second length, the second length being greater than the first length. 13. The medical implant of claim 1, wherein the acellular tissue matrix comprises a decellularized collagen-containing tissue matrix from a nonhuman animal. 14. The medical implant of claim 13, wherein the nonhuman animal is a pig. 15. The medical implant of claim 13, wherein the nonhuman animal is genetically modified such that tissues in the human animal lack galactose α-1,3-galactose epitopes. 16. The medical implant of claim 1, wherein the acellular tissue matrix lacks an epithelial basement membrane. 17. The medical implant of claim 1, wherein the acellular tissue matrix is a dermal tissue matrix. 18. The medical implant of claim 1, wherein the set of perforations is arranged in a semicircular pattern. 19. The medical implant of claim 1, wherein the set of perforations creates a mesh pattern. 20. The medical implant of claim 1, wherein the set of perforations includes a series of parallel slits, wherein the slits have a generally uniform length, wherein a generally uniform gap distance separates longitudinally-adjacent slits, and wherein a generally uniform horizontal separation distance separates adjacent parallel slits. 21. The medical implant of claim 20, wherein the length is between 0.1 and 20 mm. 22. The medical implant of claim 20, wherein the length is between 4 and 8 mm. 23. The medical implant of claim 20, wherein the gap distance is between 0.1 and 20 mm. 24. The medical implant of claim 20, wherein the gap distance is between 2 and 6 mm. 25. The medical implant of claim 20, wherein the horizontal separation distance is between 0.1 and 20 mm. 26. The medical implant of claim 20, wherein the horizontal separation distance is between 2 and 6 mm. 27. The medical implant of claim 20, wherein adjacent parallel slits are offset longitudinally with respect to each other. 28. The medical implant of claim 1, wherein the individual perforations are arcuate. 29. A method of making a graft implant, comprising: providing a sheet of biocompatible material;cutting a graft implant from the sheet of biocompatible material that is sized and shaped for conforming to a portion of a surface of a breast implant having a predetermined volume; andforming a set of perforations in the graft implant, the set of perforations including elongate slits arranged across at least a portion of the graft implant, wherein ends of longitudinally-neighboring elongate slits are arranged adjacent to each other;wherein, when the graft implant is in a planar configuration, the graft implant includes a first edge and a second edge, the first edge includes a convex portion that curves away from the second edge, and the second edge includes a convex portion that curves away from the first edge;wherein the convex portion of the first edge includes a first vertex and the convex portion of the second edge includes a second vertex;wherein the graft implant includes a longitudinal axis coincident with the graft implant and a vertical axis coincident with the graft implant, the vertical axis passing through the first and second vertices, and a distance along the longitudinal axis of the graft implant being longer than a distance along the vertical axis of the graft implant;wherein the vertical axis and the longitudinal axis are orthogonal to each other;wherein the convex portion of the first edge has a first radius of curvature and the convex portion of the second edge has a second radius of curvature, the first radius of curvature being different from the second radius of curvature;wherein the graft implant is symmetrical about the vertical axis;wherein the sheet of biocompatible material comprises an acellular tissue matrix; andwherein the set of perforations forms an arcuate pattern when the graft implant is in the planar configuration. 30. The method of claim 29, wherein the breast implant is a round implant. 31. The method of claim 29, wherein the breast implant is an anatomical implant. 32. The method of claim 29, wherein the volume of the breast implant is between 400 and 550 cc. 33. The method of claim 29, wherein the volume of the breast implant is between 250 and 400 cc. 34. The method of claim 29, wherein the volume of the breast implant is between 100 and 250 cc. 35. The method of claim 29, wherein the providing the sheet of biocompatible material comprises: providing a collagen-containing tissue from a nonhuman animal; andprocessing the tissue so as to render the tissue acellular and lacking an epithelial basement membrane, the process resulting in the production of the acellular tissue matrix. 36. The method of claim 35, wherein the nonhuman animal is a pig. 37. The method of claim 35, wherein the tissue is dermis. 38. The method of claim 35, wherein the nonhuman animal is genetically modified so that tissues in the nonhuman animal lack galactose α-1,3-galactose epitopes. 39. A method of treating tissue, comprising: providing a sheet-like sample of biocompatible material;selecting a tissue site of interest; andapplying the sample of biocompatible material to the tissue site of interest;wherein the sample of biocompatible material includes a first edge and a second edge;wherein, when the sample of biocompatible material is in a planar configuration, the first edge includes a convex portion that curves away from the second edge and the second edge includes a convex portion that curves away from the first edge;wherein the convex portion of the first edge includes a first vertex and the convex portion of the second edge includes a second vertex;wherein the sample of biocompatible material includes a longitudinal axis coincident with the sample of biocompatible material and a vertical axis coincident with the sample of biocompatible material, the vertical axis passing through the first and second vertices, and a distance along the longitudinal axis of the sample of biocompatible material being longer than a distance along the vertical axis of the sample of biocompatible material;wherein the vertical axis and the longitudinal axis are orthogonal to each other;wherein the convex portion of the first edge has a first radius of curvature and the convex portion of the second edge has a second radius of curvature, the first radius of curvature being different from the second radius of curvature;wherein the sample of biocompatible material is symmetrical about the vertical axis;wherein the sample of biocompatible material comprises an acellular tissue matrix;wherein the sample of biocompatible material has a set of perforations, the set of perforations including elongate slits arranged across at least a portion of the sample of biocompatible material, wherein ends of longitudinally-neighboring elongate slits are arranged adjacent to each other; andwherein the set of perforations forms an arcuate pattern extending along the longitudinal axis when the sheet-like sample of biocompatible material is in the planar configuration. 40. The method of claim 39, further comprising suturing the sample of biocompatible material to the tissue site of interest. 41. The method of claim 39, wherein the tissue site of interest is breast tissue. 42. The method of claim 41, further comprising: suturing a portion of the first edge to a lateral fold of the breast tissue;suturing a portion of the first edge to an inframammary fold of the breast tissue; andsuturing a portion of the second edge to an inferior edge of a pectoralis major muscle.